Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion type Assertion NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_head.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion description "[The aberrant expression of KLKs, presented in many human malignancies, highlights the significance of this gene family for early diagnosis, prognosis and monitoring of cancer patients, as it is strongly emphasized by the routine use of PSA (KLK3) for prostate cancer management.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_provenance.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion evidence source_evidence_literature NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_provenance.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion SIO_000772 20302518 NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_provenance.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion wasDerivedFrom befree-20150227 NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_provenance.
- NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_assertion wasGeneratedBy ECO_0000203 NP247992.RA9fkeGe4iw6Ir1lrZkJgY9EKMOUpu1pIkS6tLHsZ6Tus130_provenance.